Literature DB >> 28623460

Spreading of Pathology in Alzheimer's Disease.

Zhong-Yue Lv1, Chen-Chen Tan2, Jin-Tai Yu3, Lan Tan4,5.   

Abstract

The senile plaques (SPs) and neurofibrillary tangles (NFTs) are the two major pathological hallmarks of AD, which are composed of β-amyloid protein and Tau protein. So the β-amyloid protein (Aβ) and Tau oligomers (oTau) are the majority in the pathology of AD. Recently, the spreading of Aβ and oTau in the brain of AD patients has received heated value. In this review, we summarize recent research progress and aim to figure out the spreading mechanism of Aβ and Tau in AD via introduction of the formation, release, uptake, diffusion between different brain regions, and the propagation principle of Aβ and Tau. Although the mechanisms of the spreading pathology in AD are still not very clear, increasing discoveries confirm that Aβ and oTau could transmit from one neuron to another along the anatomical connected synapses. Meanwhile, a mass of studies also report that they have a totally opposite hierarchical spatiotemporal pattern of spreading in cerebral areas. In addition, Tau proteins might mediate Aβ toxicity in the brain, and they might have synergistic roles with each other. So some therapies have emerged, such as inhibiting the release, preventing the oligomerization, and blocking the uptake. This review would be helpful to comprehend the mechanism of transmission in AD and provide a new way to the targeted therapy.

Entities:  

Keywords:  Alzheimer’s disease; Aβ oligomers; Pathology; Spreading; Tau oligomers; Template; Trans-synapses

Mesh:

Substances:

Year:  2017        PMID: 28623460     DOI: 10.1007/s12640-017-9765-2

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  121 in total

1.  Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.

Authors:  Julie A Harris; Nino Devidze; Laure Verret; Kaitlyn Ho; Brian Halabisky; Myo T Thwin; Daniel Kim; Patricia Hamto; Iris Lo; Gui-Qiu Yu; Jorge J Palop; Eliezer Masliah; Lennart Mucke
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

2.  Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice.

Authors:  S Kins; A Crameri; D R Evans; B A Hemmings; R M Nitsch; J Gotz
Journal:  J Biol Chem       Date:  2001-07-25       Impact factor: 5.157

Review 3.  Amyloid oligomers: formation and toxicity of Abeta oligomers.

Authors:  Masafumi Sakono; Tamotsu Zako
Journal:  FEBS J       Date:  2010-02-09       Impact factor: 5.542

4.  Synaptic Contacts Enhance Cell-to-Cell Tau Pathology Propagation.

Authors:  Sara Calafate; Arjan Buist; Katarzyna Miskiewicz; Vinoy Vijayan; Guy Daneels; Bart de Strooper; Joris de Wit; Patrik Verstreken; Diederik Moechars
Journal:  Cell Rep       Date:  2015-05-14       Impact factor: 9.423

Review 5.  Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Ann Neurol       Date:  2011-10       Impact factor: 10.422

6.  Oligomeric amyloid-beta(1-42) induces THP-1 human monocyte adhesion and maturation.

Authors:  Nikkilina R Crouse; Deepa Ajit; Maria L D Udan; Michael R Nichols
Journal:  Brain Res       Date:  2008-12-10       Impact factor: 3.252

7.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

8.  Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons.

Authors:  Sofia Söllvander; Elisabeth Nikitidou; Robin Brolin; Linda Söderberg; Dag Sehlin; Lars Lannfelt; Anna Erlandsson
Journal:  Mol Neurodegener       Date:  2016-05-12       Impact factor: 14.195

9.  Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells.

Authors:  Marija Usenovic; Shahriar Niroomand; Robert E Drolet; Lihang Yao; Renee C Gaspar; Nathan G Hatcher; Joel Schachter; John J Renger; Sophie Parmentier-Batteur
Journal:  J Neurosci       Date:  2015-10-21       Impact factor: 6.167

10.  Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy.

Authors:  Clara Theunis; Natalia Crespo-Biel; Valérie Gafner; Maria Pihlgren; María Pilar López-Deber; Pedro Reis; David T Hickman; Oskar Adolfsson; Nathalie Chuard; Dorin Mlaki Ndao; Peter Borghgraef; Herman Devijver; Fred Van Leuven; Andrea Pfeifer; Andreas Muhs
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more
  4 in total

1.  Tau is not necessary for amyloid-β-induced synaptic and memory impairments.

Authors:  Daniela Puzzo; Elentina K Argyrousi; Agnieszka Staniszewski; Hong Zhang; Elisa Calcagno; Elisa Zuccarello; Erica Acquarone; Mauro Fa'; Domenica D Li Puma; Claudio Grassi; Luciano D'Adamio; Nicholas M Kanaan; Paul E Fraser; Ottavio Arancio
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

Review 2.  Alzheimer's Disease, Oligomers, and Inflammation.

Authors:  Gianluigi Forloni; Claudia Balducci
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Meta-analysis of the association between CD33 and Alzheimer's disease.

Authors:  Yu-Ting Jiang; Hai-Yan Li; Xi-Peng Cao; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

4.  Dietary Total Prenylflavonoids from the Fruits of Psoralea corylifolia L. Prevents Age-Related Cognitive Deficits and Down-Regulates Alzheimer's Markers in SAMP8 Mice.

Authors:  Zhi-Jing Chen; Yan-Fang Yang; Ying-Tao Zhang; Dong-Hui Yang
Journal:  Molecules       Date:  2018-01-18       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.